FindTrial
Sign In

Application of portable controller integrated ultrasonic soft tissue cutting hemostatic knife in abdominal surgery and urological surgery

A single-group, interventional, multi-center study on the application of portable controller integrated ultrasonic soft tissue cutting hemostatic knife in abdominal surgery and urology surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067982
Enrollment
Unknown
Registered
2023-02-02
Start date
2023-02-02
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases requiring abdominal surgery or urological laparoscopic surgery

Interventions

Abdominal surgery and urology operation group:Laparoscopic surgery with ultrasonic scalpel

Sponsors

Ruijin Hospital affiliated to Shanghai Jiaotong University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old, gender unlimited; 2. Patients who need to undergo abdominal surgery or urological laparoscopic surgery, and who can use ultrasonic scalpel in surgery after preliminary evaluation by the researcher; 3. Patients who are willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Can not tolerate general anesthesia, such as patients with severe heart, lung, liver, kidney and other major organ dysfunction; 2. Patients with severe coagulation dysfunction; 3. Patients with extensive metastasis in the abdomen and pelvis or extensive infiltration of surrounding tissues; 4. Patients with intestinal obstruction requiring emergency surgery: 5. Gastrointestinal perforation with acute peritonitis; 6. Patients with extensive and serious adhesion of abdominal cavity, etc., who can not be punctured to establish pneumoperitoneum; 7. Patients with body failure, massive ascites, internal bleeding or shock; 8. Severe obese patients with BMI greater than 40kg/m2: 9. Patients with poor blood sugar control in diabetes; 10. Pregnant women; 11. Patients who have participated in other interventional clinical trials or studies within 3 months: 12. Other situations that the researcher believes are not suitable to participate in this clinical study.

Design outcomes

Primary

MeasureTime frame
Tissue cutting and vascular coagulation;—

Secondary

MeasureTime frame
Operation bleeding volume;Use of other hemostatic instruments;Overall performance evaluation of equipment;—

Countries

China

Contacts

Public ContactXu Danfeng

Ruijin Hospital affiliated to Shanghai Jiaotong University Medical College

xdf12036@rjh.com.cn+86 139 0173 4568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026